SanaCutan® Basiscreme
MOPAD
Phase 3 small_molecule active
Quick answer
SanaCutan® Basiscreme for Children with a high risk of developing atopic dermatitis is a Phase 3 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Children with a high risk of developing atopic dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active